Commentary

Article

State of Science Summit- Genitourinary Cancer: Chaired by Petros Grivas, MD, PhD, and Evan Y. Yu, MD

State of Science Summit- Genitourinary Cancer: Chaired by Petros Grivas, MD, PhD, and Evan Y. Yu, MD

State of Science Summit- Genitourinary Cancer: Chaired by Petros Grivas, MD, PhD, and Evan Y. Yu, MD

Speakers

  • Petros Grivas, MD, PhD | Fred Hutchinson Cancer Center
  • Evan Y. Yu, MD | Fred Hutchinson Cancer Center
  • Tian Zhang, MD, MHS | UT Southwestern Medical Center
  • Michael Schweizer, MD | Fred Hutchinson Cancer Center
  • Scott Tykodi, MD, PhD | Fred Hutchinson Cancer Center
  • Evan Hall, MD, MPhil | University of Washington

Topics

  • Role of PARP inhibitors in Prostate Cancer
  • ‘Treatment Crossroads’: How to Choose the Best PARP Inhibitor and Why in Prostate Cancer
  • Recent Advances in Management of Metastatic Urothelial Cancer
  • Resected RCC: Adjuvant Strategies
  • Frontline Treatment of metastatic RCC
  • Salvage/2L+ Treatment of metastatic RCC

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Mazyar Shadman, MD, MPH
Petros Grivas, MD, PhD
E. Gabriela Chiorean, MD
E. Gabriela Chiorean, MD
Rohan Garje, MD
Manmeet Ahluwalia, MD, MBA, FASCO
Mazyar Shadman, MD, MPH
Petros Grivas, MD, PhD; and Chandler Park, MD, MSc, FACP
Viktor Grünwald, MD, PhD
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center